SOURCE: BDI Pharma, Inc.
COLUMBIA, SC–(Marketwire – October 11, 2010) – BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced the continuing expansion of the company’s specialty pharmaceutical portfolio with the launch of a new Animal Health Division, 4legPharma. This latest BDI Pharma expansion, focused on the biopharmaceutical needs of the veterinary specialist, is supported by the launch of its own website, www.4legpharma.com, as well as a staff of highly trained representatives dedicated to service this unique marketplace.
“As the Animal Health Division of BDI Pharma, 4legPharma is backed by over 15 years of experience in handling urgent need, critical care pharmaceutical products. We are uniquely positioned to offer veterinary specialists the best of both animal drugs as well as human therapies for extralabel use to treat pets suffering from the same chronic, life-threatening conditions that affect humans. Our customers appreciate that we deliver the safety of a secure product distribution channel and a level of personal service that is unrivaled in the veterinary medical community,” said Angela Phillips, Director of Animal Health.
The US Bureau of Labor Statistics states that the number of veterinary jobs is expected to increase thirty-three percent (33%) by 2018 as a whole, and reports published by the AVMA indicate an average annual increase of eleven percent (11%) in the number of veterinarians seeking board-certification to specialize in the areas of internal medicine, anesthesiology, dermatology, and seventeen other recognized specialties.
“At BDI Pharma, it is our commitment to bring definable value and uncompromising service to our customers and trade partners that sets us apart from others,” stated Edward Stiefel, Jr., Co-President of BDI Pharma. “Our Animal Health Division is a testament to the capabilities and resources we are willing to dedicate to service the specific nature of a growing marketplace.”
About BDI Pharma, Inc.
Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation’s healthcare community through innovative inventory supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, www.bdipharma.com has become an industry renowned point of reference. Proprietary programs for product consignment (www.consignadvantage.com), flu vaccine pre-booking (www.securiflu.com), vaccine ordering (www.securivax.com) and purchasing/reward programs (www.qoreprogram.com and www.securigam.com) round out a family of solutions tailored to the needs of the healthcare community at large.
BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.
Contact:
Brad Davis
Assistant Vice President, Marketing
(800)948-9834